Vaccinations

Scientists reveal new vaccine for recurring yeast infections

University of Georgia researchers have successfully created a vaccine that protects and treats vaginal yeast infections in mice.

Research says COVID vaccines work for 90% of immunosuppressed people

New research finds that COVID vaccines work for 90% of people who are currently immunosuppressed due to their medication.

Malaria deaths reduced by 70% with vaccine and drug combination

A combination of the world’s first malaria vaccine RTS,S/AS01E and antimalarial drugs reduce child hospitalisations and death by 70%.

Five new research projects will examine COVID-19 vaccine responses

Five new COVID-19 research projects will study the durability of vaccine responses, low responses linked with health conditions and the effect of booster shots.

Immunocompromised patients show low immune response after second vaccine

According to the OCTAVE study, immunocompromised patients presented low immune responses after two doses of the same COVID-19 vaccine.

Clinical trial to test third COVID-19 vaccine for people with weakened immune systems

A new clinical trial will investigate whether a third COVID-19 vaccine dose gives a stronger immune response for people with weakened immune systems.

Vaccinated mothers transfer COVID antibodies via breast milk

A study by the University of Florida finds that vaccinated mothers transfer COVID antibodies to babies via breast milk - suggesting that mothers can "pass on this immunity to their babies".

UK orders 35 million more Pfizer/BioNTech vaccine doses

The UK Government has signed a contract for 35 million more doses of the Pfizer/BioNTech COVID-19 vaccine, to be delivered from the second half of 2022..

FDA gives full approval to Pfizer COVID vaccine

The US Food and Drug Administration fully approved the Pfizer COVID vaccine - meaning that it is now permanently approved for use in those aged 16 and over.

Long COVID patients face increased levels of blood-clotting

Study suggests that long COVID patients are more likely to face blood-clots - even if they appeared okay, their clotting biomarkers were significantly high.

Study warns “vaccine nationalism” will create more COVID variants

Global "vaccine nationalism" is the dominant approach to the virus so far - but according to researchers at Princeton and McGill University, this mentality increases the chances of a new variant.

NHS GP says long COVID patients “shouldn’t suffer in silence”

NHS GP and lead GP at Numan, Dr Luke Pratsides tells us everything he knows about the symptoms of long COVID and what’s being done to tackle this novel disease.

COVID-19: Challenges of vaccination logistics

The challenges of vaccination logistics during the COVID-19 pandemic are charted in this updated view, written by Zisis Kozlakidis and John Litaker.

FDA approves third Pfizer dose for people with weak immune systems

The US Food and Drug Administration (FDA) have approved a third Pfizer dose for people who are immunocompromised - despite the WHO asking countries to wait until 20% were double-vaccinated, globally.

Moderna create vaccine trial for children aged 6 months and over

Moderna are enrolling roughly 13,275 participants in their vaccine trial for children - with the participants aged between six months to 12 years.

Epidemiologist says reaching herd immunity with Delta is “mythical”

Sir Andrew Pollard, head of the Oxford Vaccine Group, said on Tuesday (10 August) that herd immunity is "mythical" in relation to the Delta variant - as it still infects vaccinated individuals.

COVID-19 booster jab will offer better protection against variants

COVID-19 booster jab will protect people from existing, and potentially future, variants, according to scientists at the University of Nottingham.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders